NEW YORK (GenomeWeb) – GenMark Diagnostics reported after the close of the market on Tuesday a 28 percent rise in first quarter revenues, an increase helped by the placement of 22 of its XT-8 molecular diagnostic systems during the period.

For the three-month period ended March 31, GenMark's revenues rose to $10.1 million from $7.9 million in the same period a year earlier, in line with the average Wall Street estimate.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.